Ungar Wendy J, Paterson Michael, Cope Shannon, Kozyrskyj Anita
Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute; Department of Health Policy, Management and Evaluation, University of Toronto; Institute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, ON.
Healthc Policy. 2008 May;3(4):66-77.
Asthma is the most common chronic childhood disease, and evidence suggests that children underutilize inhaled corticosteroid ("controller") medications. Drug plans that provide benefits to children vary widely across Canada, and families may face high out-of-pocket costs. As an initial step in a knowledge exchange process aimed at motivating relevant research, a workshop was convened in March 2007 with diverse stakeholders to explore potential research topics within the theme of improving drug benefits for Canadian children with asthma. Six key challenges for further investigation were identified: (1) changing the perception of asthma from an episodic to a chronic disease, (2) improving diagnosis and management, (3) increasing intersectoral communication, (4) improving the quality of data, (5) developing better drug benefit plans and (6) practising more effective advocacy.
哮喘是儿童最常见的慢性疾病，有证据表明儿童对吸入性皮质类固醇（“控制类”）药物的使用不足。为儿童提供福利的药物计划在加拿大各地差异很大，家庭可能面临高昂的自付费用。作为旨在推动相关研究的知识交流过程的第一步，2007年3月召开了一次研讨会，邀请了不同的利益相关者，探讨在改善加拿大哮喘儿童药物福利这一主题下的潜在研究课题。确定了六个有待进一步研究的关键挑战：（1）将哮喘的观念从一种发作性疾病转变为慢性疾病，（2）改善诊断和管理，（3）加强部门间沟通，（4）提高数据质量，（5）制定更好的药物福利计划，以及（6）开展更有效的宣传。
